
No Stock Yet
No Data
Bluejay, DBV top healthcare gainers; Precision, Blueprint among losers' pack
Gainers: Bluejay Diagnostics (BJDX) +29%. DBV Technologies (DBVT) +12%. Arcellx (ACLX) +10%. Immix Biopharma (IMMX) +10%. AbCellera Biologics (ABCL) +8%. Losers: Precision BioSciences (DTIL) -10%. B
Do the Stock Experienced Heavy Trading? Immix Biopharma, Inc. (NASDAQ:IMMX), Itau Unibanco Holding S.A. (NYSE:ITUB)
Immix Biopharma, Inc. (IMMX) with the stream of 29.19% also noticed, India Itau Unibanco Holding S.A. (ITUB) encountered a rapid change of 0.56% in the last hour of trading session. Immix Biopharma,
Immix, Bright Green top healthcare gainers; while Zosano, Immunic lead losers' pack
Gainers: Immix Biopharma (IMMX) +37%. Bright Green (BGXX) +29%. Repare Therapeutics (RPTX) +29%. Yumanity Therapeutics (YMTX) +24%. PDS Biotechnology (PDSB) +15%. Losers: Zosano Pharma (ZSAN) -48%.
Immunic plunges as mid-stage trial for lead asset fails in ulcerative colitis
The shares of Immunic (NASDAQ:IMMX) crashed ~61% in the pre-market Thursday after the clinical-stage biotech said that its lead candidate vidofludimus calcium (IMU-838) did not meet the primary endpoi
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 Gainers Immix Biopharma (NASDAQ:IMMX) stock increased by 39.5% to $2.58 during Thursday's pre-market session. The market value of their outstanding shares is at $35.8 million.Repare Therapeutics (N
Top Premarket Gainers
07:42 AM EDT, 06/02/2022 (MT Newswires) -- Casi Pharmaceuticals (CASI) shares increased more than seven fold after the company's planned 1-for-10 reverse stock split took effect. Immix Biopharma (IMMX
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Immix Biopharma (NASDAQ:IMMX) stock moved upwards by 45.4% to $2.69 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 691.8K shares, which i
TherapeuticsMD, MoonLake top healthcare gainers; Outlook, Elevation Oncology lead losers' pack
Gainers: TherapeuticsMD (TXMD) +355%. MoonLake Immunotherapeutics (MLTX) +24%. Gritstone bio (GRTS) +18%. Nurix Therapeutics (NRIX) +10%. DexCom (DXCM) +9%. Losers: Outlook Therapeutics (OTLK) -54%.
Immix Biopharma Shares Slip 3.2% On 1.7M Share Offering
By Denny Jacob Immix Biopharma shares fell 3.2% to $2.60 in after-hours trading Friday after it said that it is offering about 1.7 million shares of its common stock in a secondary offering.
Immix Biopharma Offering 1.68M Shrs >IMMX
Immix Biopharma Offering 1.68M Shrs >IMMX
Loading...
No Stock Yet